Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1072625499a05c635f0ae8d259dc97ec |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12 |
filingDate |
2016-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72a2a2b816b4322e24f555df8e8f7a4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ba04aef913709b55f16acbfb79d9d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_540c5de73290697b504e209dbc7dc958 |
publicationDate |
2017-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-106632288-A |
titleOfInvention |
The preparation method of Empagliflozin |
abstract |
The invention provides a preparation method of empagliflozin, which uses (S)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran and gluconolactone as starting materials Coupling to obtain intermediate compound 3, etherification to obtain intermediate compound 4, reduction to obtain empagliflozin crude product compound 5, and refining to obtain qualified empagliflozin finished product. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114380775-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112574186-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109456314-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109988161-A |
priorityDate |
2016-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |